Oxygen chambers may ease opioid withdrawal, small study suggests

NCT ID NCT05924022

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-phase study tested whether hyperbaric oxygen therapy (breathing pure oxygen in a pressurized chamber) could reduce withdrawal symptoms in 25 adults with opioid use disorder who were gradually reducing their methadone dose. Participants received either real HBOT at two different pressures or a sham treatment. The goal was to see if HBOT made withdrawal less uncomfortable and helped people stick with their dose reductions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OPIOID-USE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Spokane Regional Health District

    Spokane, Washington, 99201, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.